nodes	percent_of_prediction	percent_of_DWPC	metapath
Tirofiban—ITGB3—Syndecan interactions—TNC—bile duct cancer	0.0471	0.0498	CbGpPWpGaD
Tirofiban—ITGA2B—Beta3 integrin cell surface interactions—TNC—bile duct cancer	0.0332	0.035	CbGpPWpGaD
Tirofiban—ITGA2B—ECM proteoglycans—TNC—bile duct cancer	0.0272	0.0288	CbGpPWpGaD
Tirofiban—ITGB3—Non-integrin membrane-ECM interactions—TNC—bile duct cancer	0.026	0.0275	CbGpPWpGaD
Tirofiban—ITGB3—Beta3 integrin cell surface interactions—TNC—bile duct cancer	0.0255	0.027	CbGpPWpGaD
Tirofiban—ITGA2B—Arf6 signaling events—HGF—bile duct cancer	0.0246	0.026	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin cell surface interactions—TNC—bile duct cancer	0.0235	0.0249	CbGpPWpGaD
Tirofiban—ITGA2B—Beta3 integrin cell surface interactions—TGFBR2—bile duct cancer	0.0227	0.024	CbGpPWpGaD
Tirofiban—ITGB3—ECM proteoglycans—TNC—bile duct cancer	0.021	0.0222	CbGpPWpGaD
Tirofiban—ITGB3—Osteopontin Signaling—MMP9—bile duct cancer	0.0207	0.0219	CbGpPWpGaD
Tirofiban—ITGA2B—Arf6 signaling events—MET—bile duct cancer	0.0194	0.0205	CbGpPWpGaD
Tirofiban—ITGB3—Arf6 signaling events—HGF—bile duct cancer	0.019	0.02	CbGpPWpGaD
Tirofiban—ITGB3—Integrin cell surface interactions—TNC—bile duct cancer	0.0181	0.0192	CbGpPWpGaD
Tirofiban—ITGB3—Beta3 integrin cell surface interactions—TGFBR2—bile duct cancer	0.0175	0.0185	CbGpPWpGaD
Tirofiban—ITGB3—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—HGF—bile duct cancer	0.0164	0.0173	CbGpPWpGaD
Tirofiban—ITGA2B—liver—bile duct cancer	0.0162	0.302	CbGeAlD
Tirofiban—ITGA2B—Axon guidance—ROBO2—bile duct cancer	0.0153	0.0162	CbGpPWpGaD
Tirofiban—ITGB3—Arf6 signaling events—MET—bile duct cancer	0.0149	0.0158	CbGpPWpGaD
Tirofiban—ITGA2B—Signal transduction by L1—EGFR—bile duct cancer	0.0148	0.0156	CbGpPWpGaD
Tirofiban—ITGB3—liver—bile duct cancer	0.0142	0.264	CbGeAlD
Tirofiban—ITGB3—Osteopontin-mediated events—MMP2—bile duct cancer	0.0137	0.0145	CbGpPWpGaD
Tirofiban—ITGB3—Integrins in angiogenesis—TGFBR2—bile duct cancer	0.0129	0.0136	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet degranulation—HGF—bile duct cancer	0.0127	0.0134	CbGpPWpGaD
Tirofiban—ITGA2B—lymph node—bile duct cancer	0.0124	0.232	CbGeAlD
Tirofiban—ITGA2B—Response to elevated platelet cytosolic Ca2+—HGF—bile duct cancer	0.0121	0.0128	CbGpPWpGaD
Tirofiban—ITGB3—Syndecan interactions—TGFB1—bile duct cancer	0.0121	0.0128	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—ROBO2—bile duct cancer	0.0118	0.0125	CbGpPWpGaD
Tirofiban—ITGB3—Signal transduction by L1—EGFR—bile duct cancer	0.0114	0.012	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—ROBO2—bile duct cancer	0.0109	0.0116	CbGpPWpGaD
Tirofiban—ITGB3—lymph node—bile duct cancer	0.0109	0.202	CbGeAlD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—TNC—bile duct cancer	0.0104	0.011	CbGpPWpGaD
Tirofiban—ITGB3—Osteopontin-mediated events—MMP9—bile duct cancer	0.0103	0.0109	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—TNC—bile duct cancer	0.0101	0.0107	CbGpPWpGaD
Tirofiban—ITGA2B—Arf6 signaling events—EGFR—bile duct cancer	0.00983	0.0104	CbGpPWpGaD
Tirofiban—ITGB3—Platelet degranulation—HGF—bile duct cancer	0.00978	0.0103	CbGpPWpGaD
Tirofiban—ITGB3—Response to elevated platelet cytosolic Ca2+—HGF—bile duct cancer	0.00932	0.00985	CbGpPWpGaD
Tirofiban—ITGB3—Molecules associated with elastic fibres—TGFB1—bile duct cancer	0.00874	0.00923	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—ROBO2—bile duct cancer	0.00842	0.0089	CbGpPWpGaD
Tirofiban—ITGB3—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—bile duct cancer	0.0081	0.00856	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—TNC—bile duct cancer	0.00778	0.00822	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—TNC—bile duct cancer	0.00776	0.0082	CbGpPWpGaD
Tirofiban—ITGB3—Arf6 signaling events—EGFR—bile duct cancer	0.00757	0.008	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling events mediated by PTP1B—EGFR—bile duct cancer	0.00716	0.00757	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—TGFBR2—bile duct cancer	0.00713	0.00754	CbGpPWpGaD
Tirofiban—ITGA2B—ECM proteoglycans—TGFB1—bile duct cancer	0.00698	0.00738	CbGpPWpGaD
Tirofiban—ITGB3—Elastic fibre formation—TGFB1—bile duct cancer	0.00681	0.00719	CbGpPWpGaD
Tirofiban—ITGA2B—Hematopoietic Stem Cell Differentiation—IL6—bile duct cancer	0.00679	0.00718	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—SMAD4—bile duct cancer	0.00675	0.00713	CbGpPWpGaD
Tirofiban—ITGB3—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—bile duct cancer	0.00668	0.00706	CbGpPWpGaD
Tirofiban—ITGB3—Non-integrin membrane-ECM interactions—TGFB1—bile duct cancer	0.00668	0.00706	CbGpPWpGaD
Tirofiban—ITGB3—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—bile duct cancer	0.00655	0.00692	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—HGF—bile duct cancer	0.00636	0.00672	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—TNC—bile duct cancer	0.00598	0.00632	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—HGF—bile duct cancer	0.00563	0.00595	CbGpPWpGaD
Tirofiban—ITGB3—Signaling events mediated by PTP1B—EGFR—bile duct cancer	0.00552	0.00583	CbGpPWpGaD
Tirofiban—ITGB3—ECM proteoglycans—TGFB1—bile duct cancer	0.00538	0.00569	CbGpPWpGaD
Tirofiban—ITGB3—Hematopoietic Stem Cell Differentiation—IL6—bile duct cancer	0.00523	0.00553	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet degranulation—TGFB1—bile duct cancer	0.00518	0.00547	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—MET—bile duct cancer	0.00517	0.00546	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—MET—bile duct cancer	0.00501	0.0053	CbGpPWpGaD
Tirofiban—ITGA2B—Response to elevated platelet cytosolic Ca2+—TGFB1—bile duct cancer	0.00493	0.00521	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—HGF—bile duct cancer	0.0049	0.00517	CbGpPWpGaD
Tirofiban—ITGA2B—L1CAM interactions—EGFR—bile duct cancer	0.00439	0.00464	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—HGF—bile duct cancer	0.00434	0.00459	CbGpPWpGaD
Tirofiban—ITGB3—Primary Focal Segmental Glomerulosclerosis FSGS—TGFB1—bile duct cancer	0.00434	0.00458	CbGpPWpGaD
Tirofiban—ITGB3—Platelet degranulation—TGFB1—bile duct cancer	0.00399	0.00421	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—MET—bile duct cancer	0.00386	0.00408	CbGpPWpGaD
Tirofiban—ITGB3—Response to elevated platelet cytosolic Ca2+—TGFB1—bile duct cancer	0.0038	0.00401	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—ERBB2—bile duct cancer	0.00366	0.00387	CbGpPWpGaD
Tirofiban—ITGB3—Cell surface interactions at the vascular wall—NRAS—bile duct cancer	0.00362	0.00382	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin-mediated Cell Adhesion—HRAS—bile duct cancer	0.00341	0.0036	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—NRAS—bile duct cancer	0.0034	0.00359	CbGpPWpGaD
Tirofiban—ITGB3—L1CAM interactions—EGFR—bile duct cancer	0.00338	0.00357	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—MET—bile duct cancer	0.00327	0.00346	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—MMP2—bile duct cancer	0.00321	0.0034	CbGpPWpGaD
Tirofiban—ITGB3—Signaling by VEGF—NRAS—bile duct cancer	0.00321	0.00339	CbGpPWpGaD
Tirofiban—ITGB3—Cell surface interactions at the vascular wall—KRAS—bile duct cancer	0.00311	0.00329	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—SMAD4—bile duct cancer	0.00305	0.00322	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—GNAS—bile duct cancer	0.00305	0.00322	CbGpPWpGaD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—NRAS—bile duct cancer	0.003	0.00317	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—KRAS—bile duct cancer	0.00293	0.00309	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—HGF—bile duct cancer	0.0029	0.00307	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—ERBB2—bile duct cancer	0.00282	0.00298	CbGpPWpGaD
Tirofiban—ITGB3—Signaling by VEGF—KRAS—bile duct cancer	0.00276	0.00292	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—MMP2—bile duct cancer	0.00273	0.00288	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—TGFB1—bile duct cancer	0.00267	0.00282	CbGpPWpGaD
Tirofiban—ITGB3—Cell surface interactions at the vascular wall—HRAS—bile duct cancer	0.00265	0.0028	CbGpPWpGaD
Tirofiban—ITGB3—Integrin-mediated Cell Adhesion—HRAS—bile duct cancer	0.00263	0.00277	CbGpPWpGaD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—KRAS—bile duct cancer	0.00258	0.00273	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—EGFR—bile duct cancer	0.00254	0.00268	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—MET—bile duct cancer	0.00252	0.00266	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—HRAS—bile duct cancer	0.00249	0.00263	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—MMP2—bile duct cancer	0.00248	0.00262	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—MMP9—bile duct cancer	0.00242	0.00255	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—ERBB2—bile duct cancer	0.00239	0.00253	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—IL6—bile duct cancer	0.00238	0.00252	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—SMAD4—bile duct cancer	0.00235	0.00248	CbGpPWpGaD
Tirofiban—ITGB3—Signaling by VEGF—HRAS—bile duct cancer	0.00235	0.00248	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—GNAS—bile duct cancer	0.00235	0.00248	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—RNF43—bile duct cancer	0.00234	0.00248	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—MET—bile duct cancer	0.00233	0.00247	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—TGFB1—bile duct cancer	0.0023	0.00243	CbGpPWpGaD
Tirofiban—ITGB3—Signaling by VEGF—IL6—bile duct cancer	0.00225	0.00237	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—HGF—bile duct cancer	0.00224	0.00236	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—NOS2—bile duct cancer	0.00223	0.00235	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—TP53—bile duct cancer	0.0022	0.00232	CbGpPWpGaD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—HRAS—bile duct cancer	0.0022	0.00232	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—MMP2—bile duct cancer	0.0021	0.00222	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—MMP9—bile duct cancer	0.00205	0.00217	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—HRAS—bile duct cancer	0.00204	0.00216	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—TGFB1—bile duct cancer	0.00199	0.0021	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—EGFR—bile duct cancer	0.00196	0.00207	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—MMP2—bile duct cancer	0.00195	0.00206	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—MMP9—bile duct cancer	0.00186	0.00197	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—ERBB2—bile duct cancer	0.00184	0.00195	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—NRAS—bile duct cancer	0.00182	0.00192	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—RNF43—bile duct cancer	0.00181	0.00191	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—MET—bile duct cancer	0.0018	0.0019	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—TGFB1—bile duct cancer	0.00177	0.00187	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—NOS2—bile duct cancer	0.00171	0.00181	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—ERBB2—bile duct cancer	0.00171	0.0018	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—EGFR—bile duct cancer	0.00166	0.00175	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—MMP9—bile duct cancer	0.00158	0.00167	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—HRAS—bile duct cancer	0.00157	0.00166	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—KRAS—bile duct cancer	0.00157	0.00165	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—TGFB1—bile duct cancer	0.00153	0.00162	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—MMP2—bile duct cancer	0.0015	0.00159	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—MMP9—bile duct cancer	0.00146	0.00155	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—NRAS—bile duct cancer	0.0014	0.00148	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—HRAS—bile duct cancer	0.00133	0.00141	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—ERBB2—bile duct cancer	0.00131	0.00139	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—NRAS—bile duct cancer	0.0013	0.00137	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—EGFR—bile duct cancer	0.00128	0.00135	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—IL6—bile duct cancer	0.00127	0.00135	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—NRAS—bile duct cancer	0.00127	0.00135	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—TGFB1—bile duct cancer	0.00121	0.00127	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—KRAS—bile duct cancer	0.00121	0.00127	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—TGFB1—bile duct cancer	0.00118	0.00125	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—EGFR—bile duct cancer	0.00118	0.00125	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—MMP9—bile duct cancer	0.00113	0.00119	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—KRAS—bile duct cancer	0.00112	0.00118	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—KRAS—bile duct cancer	0.0011	0.00116	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TGFBR2—bile duct cancer	0.00107	0.00113	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—GNAS—bile duct cancer	0.00103	0.00109	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—HRAS—bile duct cancer	0.00103	0.00108	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—SMAD4—bile duct cancer	0.00101	0.00107	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—NRAS—bile duct cancer	0.001	0.00106	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—IL6—bile duct cancer	0.000981	0.00104	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—NRAS—bile duct cancer	0.000981	0.00104	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—TP53—bile duct cancer	0.000974	0.00103	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—HRAS—bile duct cancer	0.00095	0.001	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—HRAS—bile duct cancer	0.000932	0.000985	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—TGFB1—bile duct cancer	0.000929	0.000982	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—TGFB1—bile duct cancer	0.000912	0.000963	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—EGFR—bile duct cancer	0.000911	0.000963	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—IL6—bile duct cancer	0.000909	0.000961	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—KRAS—bile duct cancer	0.000861	0.00091	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—KRAS—bile duct cancer	0.000844	0.000892	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TGFBR2—bile duct cancer	0.000825	0.000872	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—GNAS—bile duct cancer	0.000796	0.000841	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—SMAD4—bile duct cancer	0.000781	0.000825	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—TP53—bile duct cancer	0.00075	0.000793	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—HRAS—bile duct cancer	0.000732	0.000773	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—HRAS—bile duct cancer	0.000718	0.000758	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—IL6—bile duct cancer	0.0007	0.00074	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—ERBB2—bile duct cancer	0.000567	0.0006	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MMP9—bile duct cancer	0.000487	0.000514	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—ERBB2—bile duct cancer	0.000437	0.000462	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—NRAS—bile duct cancer	0.000432	0.000456	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TGFB1—bile duct cancer	0.000401	0.000424	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—EGFR—bile duct cancer	0.000393	0.000416	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MMP9—bile duct cancer	0.000375	0.000396	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—KRAS—bile duct cancer	0.000372	0.000393	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—NRAS—bile duct cancer	0.000333	0.000351	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TP53—bile duct cancer	0.00033	0.000349	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—HRAS—bile duct cancer	0.000316	0.000334	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TGFB1—bile duct cancer	0.000309	0.000327	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—EGFR—bile duct cancer	0.000303	0.00032	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IL6—bile duct cancer	0.000302	0.000319	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—KRAS—bile duct cancer	0.000286	0.000303	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TP53—bile duct cancer	0.000254	0.000269	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—HRAS—bile duct cancer	0.000243	0.000257	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IL6—bile duct cancer	0.000233	0.000246	CbGpPWpGaD
